semaglutide injection des moines Weight Loss West 'Plan to continue long-term': Ozempic

Lawsuits now claim that Novo Nordisk (Ozempic, Wegovy, Rybelsus) and Eli Lilly (Mounjaro) failed to properly warn patients of these risks, despite mounting evidence

paper in Aesthetic Surgery Journal Open Forum (doi:10.1093/asjof/ojaf030) hypothesized that long-term GLP-1RA use may produce skin atrophy through a mechanism similar to glucocorticoid-induced thinning, citing the Nagae 2018 work and other in vitro evidence

Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y

Novo Nordisk said that in a trial, patients that took a once-daily 50mg dose of amycretin lost an average of 10.4% of their weight in just three months